Assessment of the effect of sphingosine kinase inhibitors on apoptosis,unfolded protein response and autophagy of T-cell acute lymphoblastic leukemia cells; indications for novel therapeutics

C Evangelisti, C Evangelisti, G Teti, F Chiarini, M Falconi, F Melchionda, A Pession, A Bertaina, F Locatelli, JA McCubrey, DJ Baek, Robert Bittman, Susan Pyne, Nigel Pyne, AM Martelli

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Sphingosine 1-phosphate (S1P) is a bioactive lipid that is formed by the phosphorylation of sphingosine and catalysed by sphingosine kinase 1 (SK1) or sphingosine kinase 2 (SK2). Sphingosine kinases play a fundamental role in many signaling pathways associated with cancer, suggesting that proteins belonging to this signaling network represent potential therapeutic targets. Over the last years, many improvements have been made in the treatment of T-cell acute lymphoblastic leukemia (T-ALL); however, novel and less toxic therapies are still needed, especially for relapsing and chemo-resistant patients. Here, we analyzed the therapeutic potential of SKi and ROMe, a sphingosine kinase 1 and 2 inhibitor and SK2-selective inhibitor, respectively. While SKi induced apoptosis, ROMe initiated an autophagic cell death in our in vitro cell models. SKi treatment induced an increase in SK1 protein levels in Molt-4 cells, whereas it activated the endoplasmic reticulum (ER) stress/unfolded protein response (UPR) pathway in Jurkat and CEM-R cells as protective mechanisms in a sub-population of T-ALL cells. Interestingly, we observed a synergistic effect of SKi with the classical chemotherapeutic drug vincristine. In addition, we reported that SKi affected signaling cascades implicated in survival, proliferation and stress response of cells. These findings indicate that SK1 or SK2 represent potential targets for treating T-ALL.
LanguageEnglish
Pages7886-7901
Number of pages16
JournalOncotarget
Volume5
Issue number17
Early online date6 Aug 2014
Publication statusPublished - 2014

Fingerprint

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
Unfolded Protein Response
Autophagy
Apoptosis
Therapeutics
sphingosine kinase
Endoplasmic Reticulum Stress
Sphingosine
Poisons
Vincristine
Heat-Shock Proteins
Proteins
Phosphorylation
Lipids

Keywords

  • Sphingosine 1-phosphate
  • bioactive lipids
  • sphingosine
  • sphingosine kinase 1
  • apoptosis
  • autophagy
  • unfolded protein response

Cite this

Evangelisti, C., Evangelisti, C., Teti, G., Chiarini, F., Falconi, M., Melchionda, F., ... Martelli, AM. (2014). Assessment of the effect of sphingosine kinase inhibitors on apoptosis,unfolded protein response and autophagy of T-cell acute lymphoblastic leukemia cells; indications for novel therapeutics. Oncotarget, 5(17), 7886-7901.
Evangelisti, C ; Evangelisti, C ; Teti, G ; Chiarini, F ; Falconi, M ; Melchionda, F ; Pession, A ; Bertaina, A ; Locatelli, F ; McCubrey, JA ; Baek, DJ ; Bittman, Robert ; Pyne, Susan ; Pyne, Nigel ; Martelli, AM. / Assessment of the effect of sphingosine kinase inhibitors on apoptosis,unfolded protein response and autophagy of T-cell acute lymphoblastic leukemia cells; indications for novel therapeutics. In: Oncotarget. 2014 ; Vol. 5, No. 17. pp. 7886-7901.
@article{f24354797b2b4361a72a93189649979f,
title = "Assessment of the effect of sphingosine kinase inhibitors on apoptosis,unfolded protein response and autophagy of T-cell acute lymphoblastic leukemia cells; indications for novel therapeutics",
abstract = "Sphingosine 1-phosphate (S1P) is a bioactive lipid that is formed by the phosphorylation of sphingosine and catalysed by sphingosine kinase 1 (SK1) or sphingosine kinase 2 (SK2). Sphingosine kinases play a fundamental role in many signaling pathways associated with cancer, suggesting that proteins belonging to this signaling network represent potential therapeutic targets. Over the last years, many improvements have been made in the treatment of T-cell acute lymphoblastic leukemia (T-ALL); however, novel and less toxic therapies are still needed, especially for relapsing and chemo-resistant patients. Here, we analyzed the therapeutic potential of SKi and ROMe, a sphingosine kinase 1 and 2 inhibitor and SK2-selective inhibitor, respectively. While SKi induced apoptosis, ROMe initiated an autophagic cell death in our in vitro cell models. SKi treatment induced an increase in SK1 protein levels in Molt-4 cells, whereas it activated the endoplasmic reticulum (ER) stress/unfolded protein response (UPR) pathway in Jurkat and CEM-R cells as protective mechanisms in a sub-population of T-ALL cells. Interestingly, we observed a synergistic effect of SKi with the classical chemotherapeutic drug vincristine. In addition, we reported that SKi affected signaling cascades implicated in survival, proliferation and stress response of cells. These findings indicate that SK1 or SK2 represent potential targets for treating T-ALL.",
keywords = "Sphingosine 1-phosphate, bioactive lipids, sphingosine, sphingosine kinase 1, apoptosis, autophagy, unfolded protein response",
author = "C Evangelisti and C Evangelisti and G Teti and F Chiarini and M Falconi and F Melchionda and A Pession and A Bertaina and F Locatelli and JA McCubrey and DJ Baek and Robert Bittman and Susan Pyne and Nigel Pyne and AM Martelli",
year = "2014",
language = "English",
volume = "5",
pages = "7886--7901",
journal = "Oncotarget",
issn = "1949-2553",
number = "17",

}

Evangelisti, C, Evangelisti, C, Teti, G, Chiarini, F, Falconi, M, Melchionda, F, Pession, A, Bertaina, A, Locatelli, F, McCubrey, JA, Baek, DJ, Bittman, R, Pyne, S, Pyne, N & Martelli, AM 2014, 'Assessment of the effect of sphingosine kinase inhibitors on apoptosis,unfolded protein response and autophagy of T-cell acute lymphoblastic leukemia cells; indications for novel therapeutics' Oncotarget, vol. 5, no. 17, pp. 7886-7901.

Assessment of the effect of sphingosine kinase inhibitors on apoptosis,unfolded protein response and autophagy of T-cell acute lymphoblastic leukemia cells; indications for novel therapeutics. / Evangelisti, C; Evangelisti, C; Teti, G; Chiarini, F; Falconi, M; Melchionda, F; Pession, A; Bertaina, A; Locatelli, F; McCubrey, JA; Baek, DJ; Bittman, Robert; Pyne, Susan; Pyne, Nigel; Martelli, AM.

In: Oncotarget, Vol. 5, No. 17, 2014, p. 7886-7901.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Assessment of the effect of sphingosine kinase inhibitors on apoptosis,unfolded protein response and autophagy of T-cell acute lymphoblastic leukemia cells; indications for novel therapeutics

AU - Evangelisti, C

AU - Evangelisti, C

AU - Teti, G

AU - Chiarini, F

AU - Falconi, M

AU - Melchionda, F

AU - Pession, A

AU - Bertaina, A

AU - Locatelli, F

AU - McCubrey, JA

AU - Baek, DJ

AU - Bittman, Robert

AU - Pyne, Susan

AU - Pyne, Nigel

AU - Martelli, AM

PY - 2014

Y1 - 2014

N2 - Sphingosine 1-phosphate (S1P) is a bioactive lipid that is formed by the phosphorylation of sphingosine and catalysed by sphingosine kinase 1 (SK1) or sphingosine kinase 2 (SK2). Sphingosine kinases play a fundamental role in many signaling pathways associated with cancer, suggesting that proteins belonging to this signaling network represent potential therapeutic targets. Over the last years, many improvements have been made in the treatment of T-cell acute lymphoblastic leukemia (T-ALL); however, novel and less toxic therapies are still needed, especially for relapsing and chemo-resistant patients. Here, we analyzed the therapeutic potential of SKi and ROMe, a sphingosine kinase 1 and 2 inhibitor and SK2-selective inhibitor, respectively. While SKi induced apoptosis, ROMe initiated an autophagic cell death in our in vitro cell models. SKi treatment induced an increase in SK1 protein levels in Molt-4 cells, whereas it activated the endoplasmic reticulum (ER) stress/unfolded protein response (UPR) pathway in Jurkat and CEM-R cells as protective mechanisms in a sub-population of T-ALL cells. Interestingly, we observed a synergistic effect of SKi with the classical chemotherapeutic drug vincristine. In addition, we reported that SKi affected signaling cascades implicated in survival, proliferation and stress response of cells. These findings indicate that SK1 or SK2 represent potential targets for treating T-ALL.

AB - Sphingosine 1-phosphate (S1P) is a bioactive lipid that is formed by the phosphorylation of sphingosine and catalysed by sphingosine kinase 1 (SK1) or sphingosine kinase 2 (SK2). Sphingosine kinases play a fundamental role in many signaling pathways associated with cancer, suggesting that proteins belonging to this signaling network represent potential therapeutic targets. Over the last years, many improvements have been made in the treatment of T-cell acute lymphoblastic leukemia (T-ALL); however, novel and less toxic therapies are still needed, especially for relapsing and chemo-resistant patients. Here, we analyzed the therapeutic potential of SKi and ROMe, a sphingosine kinase 1 and 2 inhibitor and SK2-selective inhibitor, respectively. While SKi induced apoptosis, ROMe initiated an autophagic cell death in our in vitro cell models. SKi treatment induced an increase in SK1 protein levels in Molt-4 cells, whereas it activated the endoplasmic reticulum (ER) stress/unfolded protein response (UPR) pathway in Jurkat and CEM-R cells as protective mechanisms in a sub-population of T-ALL cells. Interestingly, we observed a synergistic effect of SKi with the classical chemotherapeutic drug vincristine. In addition, we reported that SKi affected signaling cascades implicated in survival, proliferation and stress response of cells. These findings indicate that SK1 or SK2 represent potential targets for treating T-ALL.

KW - Sphingosine 1-phosphate

KW - bioactive lipids

KW - sphingosine

KW - sphingosine kinase 1

KW - apoptosis

KW - autophagy

KW - unfolded protein response

UR - http://www.impactjournals.com/oncotarget/misc/linkedout.php?pii=2318

M3 - Article

VL - 5

SP - 7886

EP - 7901

JO - Oncotarget

T2 - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 17

ER -